Evaxion Biotech AS (EVAX)
0.919
+0.03
(+3.25%)
USD |
NASDAQ |
Dec 20, 16:00
0.9018
-0.02
(-1.87%)
After-Hours: 20:00
Evaxion Biotech Profit Margin (Quarterly): -64.14% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 38.28% |
| Ascendis Pharma AS | -171.5% |
| DBV Technologies SA | -- |
| Adaptimmune Therapeutics PLC | -43.07% |
| Akari Therapeutics PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -69.51% |
| Return on Invested Capital | -239.0% |
| Operating Margin (Quarterly) | -57.37% |